Clinical Chemistry, Malmö
961 – 970 of 1289
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Innovators in urology : Introduction
(
- Contribution to journal › Debate/Note/Editorial
- 2002
-
Mark
Factor V and thrombotic disease: description of a janus-faced protein.
(
- Contribution to journal › Scientific review
-
Mark
Defining the factor Xa-binding site on factor Va by site-directed glycosylation.
(
- Contribution to journal › Article
-
Mark
Localization of phosphatidylserine binding sites to structural domains of factor X-a
(
- Contribution to journal › Article
-
Mark
HLA-DQ genotypes in classic type 1 diabetes and in latent autoimmune diabetes of the adult.
(
- Contribution to journal › Article
-
Mark
Structural requirements for the intracellular subunit polymerization of the complement inhibitor C4b-binding protein.
(
- Contribution to journal › Article
-
Mark
Approved IFCC reference method for the measurement of HbA1c in human blood.
(
- Contribution to journal › Article
-
Mark
Prediction of tumor heterogeneity in localized prostate cancer
(
- Contribution to journal › Article
-
Mark
Semenogelin I and II, the predominant human seminal plasma proteins, are also expressed in non-genital tissues.
(
- Contribution to journal › Article
-
Mark
Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.
(
- Contribution to journal › Article